Holdings of T. Rowe Price Health Sciences Fund, Inc.
T. ROWE PRICE HEALTH SCIENCES FUND, INC. ·168 declared positions · as of Mar 31, 2026
Original filing · Net assets 10.9B $ · Ten largest lines: 42.2 % of the equity sleeve
Sector breakdown
- Health care 67.2 %
- Industrials 0.7 %
- Materials 0.5 %
- Consumer discretionary 0.2 %
- Unattributed 31.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.8 %
- HKD 1.3 %
- JPY 0.6 %
- CHF 0.2 %
- EUR 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- US 88.3 %
- GB 3.4 %
- NL 3.3 %
- BM 1.4 %
- HK 1.3 %
- JP 0.6 %
- KY 0.5 %
- FR 0.5 %
- CH 0.2 %
- DK 0.2 %
- SG 0.2 %
- VG 0.1 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 148 | 9B $ | 88.34 % |
| GB | 2 | 348.8M $ | 3.43 % |
| NL | 3 | 332.1M $ | 3.26 % |
| BM | 2 | 138M $ | 1.36 % |
| HK | 1 | 129.2M $ | 1.27 % |
| JP | 1 | 62.9M $ | 0.62 % |
| KY | 4 | 55.2M $ | 0.54 % |
| FR | 2 | 53.5M $ | 0.53 % |
| CH | 1 | 24.1M $ | 0.24 % |
| DK | 1 | 16.4M $ | 0.16 % |
| SG | 1 | 15.3M $ | 0.15 % |
| VG | 1 | 10.4M $ | 0.10 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Tango Therapeutics Inc | 638,486 | 13.4M $ | 0.12 % |
| Relay Therapeutics Inc | 1,299,962 | 12.9M $ | 0.12 % |
| Repligen Corp | 108,730 | 12.8M $ | 0.12 % |
| Bicara Therapeutics Inc | 642,514 | 12.8M $ | 0.12 % |
| Cogent Biosciences Inc | 326,181 | 12.6M $ | 0.12 % |
| Viatris Inc | 927,240 | 12.5M $ | 0.12 % |
| Tarsus Pharmaceuticals Inc | 175,856 | 12.3M $ | 0.11 % |
| Ocular Therapeutix Inc | 1,439,766 | 12.2M $ | 0.11 % |
| Disc Medicine Inc | 186,605 | 11.9M $ | 0.11 % |
| Tyra Biosciences Inc | 307,082 | 11.8M $ | 0.11 % |
| Molina Healthcare Inc | 85,655 | 11.4M $ | 0.10 % |
| Medpace Holdings Inc | 22,932 | 11M $ | 0.10 % |
| Replimune Group Inc | 1,427,764 | 10.9M $ | 0.10 % |
| Corvus Pharmaceuticals Inc | 725,099 | 10.6M $ | 0.10 % |
| Biohaven Ltd | 1,228,554 | 10.4M $ | 0.10 % |
| Climb Bio Inc | 1,468,417 | 10.1M $ | 0.09 % |
| Kyverna Therapeutics Inc | 1,142,161 | 9.9M $ | 0.09 % |
| Liquidia Corp | 260,626 | 9.8M $ | 0.09 % |
| Cullinan Therapeutics Inc | 686,764 | 9.8M $ | 0.09 % |
| Olema Pharmaceuticals Inc | 649,181 | 9.7M $ | 0.09 % |
| Pharvaris NV | 331,529 | 9.4M $ | 0.09 % |
| Allogene Therapeutics Inc | 3,830,998 | 9.3M $ | 0.09 % |
| Lantheus Holdings Inc | 122,170 | 9.3M $ | 0.09 % |
| Denali Therapeutics Inc | 468,129 | 9M $ | 0.08 % |
| Atrium Therapeutics Inc | 666,325 | 8.9M $ | 0.08 % |
| Shattuck Labs Inc | 1,366,288 | 8.8M $ | 0.08 % |
| Ideaya Biosciences Inc | 259,143 | 8.6M $ | 0.08 % |
| SENSORION SA | 16,950,906 | 8M $ | 0.07 % |
| SpyGlass Pharma Inc | 290,792 | 7.5M $ | 0.07 % |
| PROCEPT BIOROBOTICS CORP | 289,633 | 7.2M $ | 0.07 % |
| Iovance Biotherapeutics Inc | 2,047,047 | 7.2M $ | 0.07 % |
| Viridian Therapeutics Inc | 343,846 | 6.7M $ | 0.06 % |
| Alto Neuroscience Inc | 268,280 | 6M $ | 0.06 % |
| Inspire Medical Systems Inc | 116,160 | 6M $ | 0.06 % |
| Aktis Oncology Inc | 333,745 | 6M $ | 0.05 % |
| Evommune Inc | 246,092 | 5.7M $ | 0.05 % |
| IMMATICS NV | 495,393 | 4.9M $ | 0.04 % |
| Xencor Inc | 378,576 | 4.6M $ | 0.04 % |
| Entrada Therapeutics Inc | 329,233 | 4.2M $ | 0.04 % |
| CRESCENT BIOPHARMA INC | 221,065 | 4.1M $ | 0.04 % |
| ZAI LAB LTD | 213,174 | 4M $ | 0.04 % |
| Tectonic Therapeutic Inc | 122,254 | 3.8M $ | 0.03 % |
| Eikon Therapeutics Inc | 349,098 | 3.7M $ | 0.03 % |
| Bicycle Therapeutics PLC | 739,251 | 3.4M $ | 0.03 % |
| Generate Biomedicines Inc | 265,641 | 3.3M $ | 0.03 % |
| Immuneering Corp | 624,026 | 3.3M $ | 0.03 % |
| BridgeBio Oncology Therapeutics Inc | 333,485 | 3M $ | 0.03 % |
| Immix Biopharma Inc | 326,401 | 3M $ | 0.03 % |
| Agios Pharmaceuticals Inc | 70,221 | 2.4M $ | 0.02 % |
| SALUDA MEDICAL INC | 3,958,452 | 2.3M $ | 0.02 % |
| Enliven Therapeutics Inc | 53,863 | 2.1M $ | 0.02 % |
| Hims & Hers Health Inc | 97,648 | 2M $ | 0.02 % |
| Immunovant Inc | 81,427 | 2M $ | 0.02 % |
| Monopar Therapeutics Inc | 34,428 | 1.9M $ | 0.02 % |
| Rocket Pharmaceuticals Inc | 464,628 | 1.7M $ | 0.02 % |
| Cabaletta Bio Inc | 608,501 | 1.6M $ | 0.02 % |
| Adlai Nortye Ltd. | 219,665 | 1.5M $ | 0.01 % |
| Aura Biosciences Inc | 221,135 | 1.5M $ | 0.01 % |
| LENZ Therapeutics Inc | 144,751 | 1.3M $ | 0.01 % |
| Beta Bionics Inc | 113,126 | 1.1M $ | 0.01 % |
| RadNet Inc | 18,038 | 1M $ | 0.01 % |
| MediWound Ltd | 62,181 | 1M $ | 0.01 % |
| Annexon Inc | 176,618 | 978.5K $ | 0.01 % |
| Nuvation Bio Inc | 186,516 | 800.2K $ | 0.01 % |
| REVOLUTION MEDICINES INC WTS 12/26 | 198,505 | 345.4K $ | 0.00 % |
| Janux Therapeutics Inc | 22,599 | 314.1K $ | 0.00 % |
| Ginkgo Bioworks Holdings Inc | 23,550 | 144.4K $ | 0.00 % |
| GENEDX HOLDINGS CORP WTS 7/26 | 206,747 | 1.7K $ |